Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 130-135 , November 2006

Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice

  • Verena Quennet

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • Shared first authorship.
    • ,
  • Ala Yaromina

      Affiliations

    • Department of Radiation Oncology
    • Shared first authorship.
    • ,
  • Daniel Zips

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Andrea Rosner

      Affiliations

    • Department of Radiation Oncology
    • ,
  • Stefan Walenta

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • ,
  • Michael Baumann

      Affiliations

    • Department of Radiation Oncology
    • Experimental Center, and
    • OncoRay-Centre for Radiation Research in Oncology, University of Technology Dresden Germany
    • Shared senior authorship.
    • ,
  • Wolfgang Mueller-Klieser

      Affiliations

    • Institute of Physiology and Pathophysiology, University of Mainz, Germany
    • Corresponding Author InformationCorresponding author. Wolfgang Mueller-Klieser, Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, D-55128 Mainz, Germany.
    • Shared senior authorship.

Received 18 January 2006 ,Revised 24 July 2006 ,Accepted 11 August 2006.

References 

  1. Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol. 1994;32:1–11
  2. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr. 1997;29:355–364
  3. Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:349–353
  4. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004;4:891–899
  5. Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002;62:3909–3913
  6. Gottfried E, Kunz-Schughart LA, Ebner S, et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006;107:2013–2021
  7. Hessel F, Krause M, Helm A, et al. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation. Int J Radiat Biol. 2004;80:719–727
  8. Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266–276
  9. Janssen HL, Hoebers FJ, Sprong D, et al. Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors. Radiother Oncol. 2004;70:91–97
  10. Krause U, Wegener G. Control of glycolysis in vertebrate skeletal muscle during exercise. Am J Physiol. 1996;270:R821–R829
  11. Laprie A, Pirzkall A, Haas-Kogan DA, et al. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:20–31
  12. Lin X, Zhang F, Bradbury CM, et al. 2-Deoxy-d-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res. 2003;63:3413–3417
  13. Mallet RT. Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med. 2000;223:136–148
  14. Mueller-Klieser W, Walenta S. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J. 1993;25:407–420
  15. Nordsmark M, Loncaster J, Aquino-Parsons C, et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol. 2003;67:35–44
  16. Raizer JJ, Koutcher JA, Abrey LE, et al. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neurooncol. 2005;71:173–180
  17. Rajendran JG, Mankoff DA, O’Sullivan F, et al. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10:2245–2252
  18. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8:S62–S67
  19. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9:539–549
  20. Troost EG, Bussink J, Kaanders JH, et al. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. Radiother Oncol. 2005;76:194–199
  21. Walenta S, Chau TV, Schroeder T, et al. Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?. J Cancer Res Clin Oncol. 2003;129:321–326
  22. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;14:267–274
  23. Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem. 2004;11:2195–2204
  24. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916–921
  25. Xu M, See SJ, Ng WH, et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery. 2005;56:919–926
  26. Yaromina A, Holscher T, Eicheler W, et al. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiother Oncol. 2005;76:206–212
  27. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun. 2004;313:459–465

☆ Financial support: This investigation was supported by grants of the Deutsche Forschungsgemeinschaft to W.M.K. (Mu 576/14-1) and to M.B. and D.Z. (Ba 1433/4-2).

PII: S0167-8140(06)00374-4

doi: 10.1016/j.radonc.2006.08.012

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 130-135 , November 2006

Article Tools

* Image Usage & Resolution